Glauconix Biosciences, Inc.
Feryan Ahmed's work experience begins in 1999 when they joined AMRI as a Scientist. They worked at AMRI for 13 years, until December 2012. In 2014, Ahmed became a Co-Founder and CTO at Humonix Biosciences, Inc. They also worked as a Research Assistant at the College of Nanoscale Science and Engineering from January 2014 to May 2015. Most recently, in December 2022, Ahmed joined Lhasa Limited as a Senior Application Scientist.
Feryan Ahmed has a Doctor of Philosophy - PhD from the University of Minnesota. Before that, their education history includes attending Macalester College, but no specific degree or field of study is provided.
This person is not in any teams
Glauconix Biosciences, Inc.
www.glauconix-biosciences.com Glauconix Biosciences is a specialty pharma research company that uses an innovative platform technology to reduce the cost of ophthalmic drug development. Glauconix operates out of its laboratories located at the SUNY Polytechnic Institute-Albany, NY campus. We collaborate with academic and industry partners to help screen, identify and validate the unique MOA of the most effective drug candidates. Glauconix’s 3D tissue system can reduce the risk of clinical trial failure; saving time, labor and development costs. Early identification and validation of effective compounds or biologics, allows partners to confidently enter clinical trial.